Form 4 for BNGO Bionano Genomics, Inc.
Accepted 2024-06-05 00:00:00 ET · period of report 2024-06-03 · accession 0001415889-24-015621 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-06-05 | 2024-06-03 | BNGO | Holmlin R. Erik | Pres AND CEO, Dir | A - Grant | $0.00 | +44.0K | 121.8K | +57% | $0 |
| D | 2024-06-05 | 2024-06-03 | BNGO | Holmlin R. Erik | Pres AND CEO, Dir | A - Grant | $0.00 | +204.0K | 204.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-06-03 | A | A | 44,000 | $0.00 | 121,813 | D | — | — | (F1) Represents restricted stock unit award granted under the Issuer's 2018 Equity Incentive Plan. (F2) The shares subject to the RSUs vest 1/4th annually beginning on the one-year anniversary of the grant date. (F3) Includes 150 shares acquired under the Issuer's 2018 Employee Stock Purchase Plan (the "ESPP") on June 9, 2023. |
| 2 | Derivative | Stock Option (Right to Buy) | 2024-06-03 | A | A | 204,000 | $0.00 | 204,000 | D | $0.93 · — to 2034-06-02 | 204,000 Common Stock | (F4) The shares subject to the option shall vest monthly over 48 months beginning on the one-month anniversary of June 3, 2024 (the "Grant Date") such that the option shall be fully vested and exercisable on the four-year anniversary of the Grant Date. |